SmartCella Holding
Business Services · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Alfred Nobels Alle 150, Stockholm, Stock...Phone Number
+46 768117744Website
www.smartcella.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
1
1
1
1
About SmartCella Holding
SmartCella is a Swedish company focused on advancing healthcare through innovative cell-based therapies and cutting-edge drug delivery technologies. They specialize in targeted delivery systems, such as the Extroducer catheter, and are developing novel stem cell-based therapies for conditions like cardiac failure and Parkinson's disease. Their intended clients include healthcare providers and patients in need of advanced therapeutic solutions. Founded in 2014, SmartCella combines a diverse team of scientists, innovators, and entrepreneurs to address critical health needs.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SmartCella Holding your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when SmartCella Holding launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if SmartCella Holding is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at SmartCella Holding
Click to see if SmartCella Holding had a recent Job posting/layoffs
SmartCella Holding, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once SmartCella Holding has new funding data
Check if SmartCella Holding has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on SmartCella Holding recently announced quarterly report
Recommended Actions
Find VP level buyers at SmartCella Holding
Find 3 more new buyers
Company Profile Activity
Activity Insights
SmartCella Holding is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SmartCella Holding is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SmartCella Holding.
SmartCella Holding Tech Stack
A closer look at the technologies used by SmartCella Holding
See more technologies
SmartCella Holding News & Media
XyloCor and SmartCella enter into license agreement for use of the Extroducer to administer novel gene therapy XC001 to the heart
· The Extroducer® Infusion Catheter System ® enables local delivery of XC001 to the heart without the need for surgery. · XC001 has achieved positive Phase 1/2 results in the EXACT Trial validating its transformative potential for treatment of refractory angina in patients who have exhausted available treatment options and have a debilitating quality-of-life. Wayne, PA, and Tullinge, Sweden July 10, 2024 —XyloCor Therapeutics, Inc. (“XyloCor”), a clinical‑stage biopharmaceutical company developiSmartCella raises EUR 50 million to accelerate growth and commercialization
SmartCella Holding AB (“SmartCella”) today announces a new share issue raising approximately EUR 50 million to accelerate growth and support commercialization of the Extroducer and the company’s cell and mRNA operations. The share issue was supported by existing large institutional investors such as Fjärde AP-fonden, AMF Pension and SEB-Stiftelsen, as well as a new long-term strategic investor, AstraZeneca (committing to approximately half of the share issue) and the new larger institutional invSenior life science and medical specialists join SmartCella’s Board of Directors
SmartCella Holding AB (“SmartCella”) held its 2024 Annual General Meeting on June 10. The company welcomed investors to its state-of-the art clinical GMP manufacturing facility in Stockholm to learn more about the progress of SmartCella during the last 12 months. In addition, the investors met and interacted with the new board members who all hold unique life science industry and medical expertise. The newly appointed Board of Directors will play a pivotal role as SmartCella
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SmartCella Holding
Sign Up For FreeTo access detailed company insights
SmartCella is a Swedish company focused on advancing healthcare through innovative cell-based therapies and cutting-edge drug delivery technologies. They specialize in targeted delivery systems, such as the Extroducer catheter, and are developing novel stem cell-based therapies for conditions like cardiac failure and Parkinson's disease. Their inte... Read More
